BLK vs PFE: Which Is the Better Buy?

Side-by-side comparison of BlackRock, Inc. and Pfizer Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-21.
BlackRock, Inc. ยท Financial Services
$1,069.78
+44.0% upside to fair value
High Conviction Grade A High Quality
VS
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
BLK has more upside to fair value (+44.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric BLK PFE
Current Price $1,069.78 $27.64
Fair Value Estimate $1,540.94 $30.94
Upside to Fair Value +44.0% +12.0%
Market Cap $165.8B $157.5B
Forward P/E โ€” โ€”
EV / EBITDA 15.9x 17.4x
Price / Sales 6.1x 2.5x
Price / FCF 71.5x 14.3x
Revenue Growth YoY +30.6% +2.6%
Gross Margin 55.7% 71.3%
Operating Margin 31.1% 25.1%
Return on Equity 11.7% 4.9%
Dividend Yield 2.09% 6.22%
FCF Yield 1.4% 6.97%
Analyst Consensus Strong Buy Hold
Investment Thesis
BLK โ€” BlackRock, Inc.
BlackRock is the world's largest asset manager, overseeing $15.345 trillion in assets across ETFs, active strategies, alternatives, and the Aladdin investment-technology platform, serving institutional, intermediary, and individual clients globally. The business quality is high: TTM gross margin of 55.7%, operating margin of 31.1%, and net margin of 24.1% reflect the scalability of a fee-based moโ€ฆ
PFE โ€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โ€ฆ
Accumulation Zones
Metric BLK PFE
Zone Low $1,155.70 $23.21
Zone High $1,309.80 $26.30
In Buy Zone? Yes No
โ† BLK Research    PFE Research โ†’    All Research